Company Filing History:
2 out of 601 
2 out of 38 
1 out of 1 Years Active: 2000-2009
Title: The Innovations of Andres Metspalu
Introduction
Andres Metspalu is a prominent inventor based in Tartu, Estonia. He has made significant contributions to the field of genetics and biotechnology, holding a total of 4 patents. His work focuses on methods for analyzing nucleic acids and biological materials, showcasing his expertise in the life sciences.
Latest Patents
One of Metspalu's latest patents is a method to determine single nucleotide polymorphisms (SNPs) and mutations in nucleic acid sequences. This genotyping method utilizes a prepared oligomicroarray as a device to identify SNPs and mutations. The innovative approach employs two specific APEX-2 primers for each SNP or mutation, which are used during both the amplification phase and the single base extension phase on an array. This allows for the genotyping and amplification of all SNP-containing sequences in a single reaction tube, which can then be visualized on a microarray.
Another notable patent involves a method and apparatus for the detection and analysis of biological materials through laser-induced fluorescence. This invention provides a fast and accurate way to analyze biological samples. The method includes prior mapping of the DNA chip with a CCD camera, addressed excitation of samples, and recording of fluorescence spectra using an ultra-fast spectrometer.
Career Highlights
Throughout his career, Metspalu has worked with esteemed organizations such as Baylor College of Medicine and Pharmacia Biotech AB. His experience in these institutions has contributed to his development as a leading figure in genetic research and innovation.
Collaborations
Metspalu has collaborated with notable professionals in his field, including C. Thomas Caskey and John Shumaker. These partnerships have further enhanced his research and contributions to biotechnology.
Conclusion
Andres Metspalu's work exemplifies the intersection of innovation and biotechnology. His patents reflect a commitment to advancing genetic analysis techniques, making significant strides in the understanding of nucleic acids and biological materials.